synagis jcode

Synagis -

Synagis (palivizumab) is proven and medically necessary to prevent serious respiratory syncytial virus disease (RSV) in high risk infants and young children ...

Coding Guideline for Synagis® (palivizumab)

Criteria for Coverage. Synagis® (palivizumab) will be allowed monthly during the RSV season, October 19th – April 21st. Patient must meet the most current ...

similar Search

Last Search

By using our site you agree to our use of cookies to deliver a better site experience.